Investors in Health

MIF II, founded in 2015 by Schiphol, KLM, TU Delft, NS, and Port of Amsterdam in collaboration with @NBI Investors, represents a strategic partnership aimed at accelerating entrepreneurial ventures. Combining Venture Capital funding with the specialized expertise and expansive global network of its founding partners, MIF II supports innovative initiatives in Logistics, Transport, and Innovation. Building on the success of Mainport Innovation Fund I, which closed in 2015 after ten impactful investments, MIF II focuses on advancing sustainable infrastructure, connectivity, mobility solutions, intermodal transport, energy innovations, digitization, IoT applications, security and safety enhancements, seamless travel experiences, and big data analytics. By nurturing pioneering technologies and business models, MIF II aims to drive transformative change and shape the future of these critical sectors.

MedSciences Capital (MSC) is a dedicated venture capital provider focused on supporting early- and mid-stage companies at the forefront of developing innovative products in the healthcare and life sciences sectors. With a mission to drive advancements in medical technologies and healthcare solutions, MedSciences Capital strategically invests in companies poised to make significant impacts on patient care and industry standards. Their investment approach combines financial support with strategic guidance and operational expertise, helping entrepreneurs navigate challenges and scale their innovations effectively. MSC's portfolio spans a wide range of healthcare innovations, including medical devices, biotechnology advancements, pharmaceuticals, and digital health solutions. By fostering partnerships and leveraging their extensive network, MedSciences Capital plays a crucial role in accelerating the development and commercialization of groundbreaking healthcare technologies that address global health challenges.

MMVentures is a Netherlands-based investment firm specializing in supporting startups and scale-ups with high growth potential. With a focus on early-stage ventures, MMVentures plays a crucial role in nurturing promising companies through strategic investments and operational support. Their approach involves identifying innovative business models and technologies across various sectors, including technology, healthcare, and sustainability. By leveraging their expertise and network, MMVentures aims to fuel entrepreneurial success and drive impactful growth in the startup ecosystem. Their commitment to partnering with ambitious founders underscores their role in facilitating innovation and economic development

Noaber focuses on driving transformative change aimed at enhancing health outcomes. Their mission emphasizes improving both health and the quality of care through strategic programs and investments. By actively participating in initiatives and partnerships, Noaber aims to maximize impact across healthcare systems, focusing on improving patient experiences, enhancing healthcare professional satisfaction, and ultimately reducing overall care costs—a concept known as the quadruple aim in healthcare management.

Granpool Innovative Investments is a trusted partner for entrepreneurs, dedicated to fostering innovation and growth in early-stage companies. With a focus on cutting-edge technologies and disruptive business models, Granpool provides essential capital and strategic support to startups across various industries. Their investment approach is characterized by a deep commitment to collaboration, working closely with founders to navigate challenges and seize opportunities. By leveraging their extensive network and expertise, Granpool empowers entrepreneurs to scale their businesses and achieve long-term success. The firm's dedication to driving impactful change ensures that their portfolio companies are well-positioned to lead in their respective markets, contributing to a more dynamic and forward-thinking business landscape. Through active partnership and unwavering support, Granpool Innovative Investments helps shape the future of innovation.

Advent Life Sciences is a venture capital firm dedicated to investing in life sciences businesses. Focusing on innovative companies in biotechnology, pharmaceuticals, medical devices, and diagnostics, Advent Life Sciences supports the development of breakthrough technologies and therapies. By providing capital and strategic expertise, the firm helps entrepreneurs navigate the complexities of the life sciences sector, accelerating the path from research to market. Advent Life Sciences is committed to advancing healthcare solutions that improve patient outcomes and address unmet medical needs globally.

NCL Technology Ventures specializes in healthcare investments, recognizing the modernization of healthcare as a significant growth driver in the 21st century. As a dedicated healthcare investor, NCL identifies and supports companies pioneering transformational changes in the sector. They provide transformational equity capital and strategic expertise to companies leveraging innovation and technology to advance healthcare solutions. NCL's mission is to foster companies that innovate in preventing, treating, and curing various medical conditions, thereby addressing future health challenges and creating valuable businesses. By navigating the dynamic healthcare landscape, NCL Technology Ventures aims to achieve clinical and commercial success for its portfolio companies.

Nickleby Capital is a private investment office that collaborates with influential families and entrepreneurs to offer differentiated capital solutions. They specialize in providing strategic investments and advisory services tailored to the unique needs of their partners. Nickleby Capital's approach focuses on building long-term relationships and creating value through thoughtful and innovative investment strategies. With a commitment to integrity and personalized service, they aim to support the growth and sustainability of businesses and investment opportunities. Nickleby Capital plays a pivotal role in leveraging its network and expertise to empower partners and drive successful outcomes in the investment landscape.

VGC Partners is a growth capital investment firm focused on supporting businesses in scaling their operations and achieving significant growth milestones. They specialize in providing strategic capital to high-potential companies across various sectors, helping them expand their market presence and enhance operational capabilities. VGC Partners adopts a hands-on approach, working closely with management teams to navigate challenges and capitalize on opportunities for growth. With a commitment to long-term value creation, VGC Partners plays a pivotal role in accelerating the success of growth-stage enterprises and maximizing their potential in the competitive landscape.

Old College Capital serves as the venture investment arm of the University of Edinburgh, specializing in providing growth and development finance to startups. Focused on fostering innovation and entrepreneurship, they support early-stage companies across various sectors. Old College Capital leverages its deep ties to academia and industry to identify promising ventures and provide them with strategic capital and mentorship. By nurturing the commercialization of research and ideas, they contribute to the expansion of innovative solutions and technologies. Old College Capital plays a pivotal role in driving economic growth and societal impact through its investments in the vibrant startup ecosystem.

Swordfish Investments, now operating as AyBe Capital, employs a comprehensive investment strategy that spans multiple asset classes. We invest directly and through funds across a diverse range of sectors including technology, media, real estate, strategic land, sports, consumer retail, and health. At Swordfish Investments (AyBe Capital), we follow our curiosities and maintain a keen interest in innovative opportunities. If a venture captivates our interest, we're eager to explore its potential. We are dedicated to partnering with ambitious entrepreneurs and founders. We understand that groundbreaking ideas require not only capital but also patience and support. Thus, we prioritize building enduring and impactful long-term relationships with our partners.

Octopus Group, we are both entrepreneurs and investors driven by a mission to support the people, ideas, and industries that can drive positive change in the world. As entrepreneurs, we build our own businesses to tackle significant societal challenges. Octopus Energy, our flagship energy transition business, is a prime example of this commitment. As investors, we manage £12.9 billion entrusted by our clients, directing more than 78% of these funds towards empowering people, revitalizing healthcare, and promoting a sustainable planet. At our core, we believe that how a company behaves is just as important as what it does. That’s why we chose to become an accredited B Corp (the equivalent of a Fairtrade coffee stamp but for companies) and to change our Articles of Association so that the interests of all our stakeholders – employees, customers, communities, environment, and shareholders – are considered in every decision we make. Octopus Investments, Octopus Energy, Octopus Money, Australia, Seccl Technology, Aurora, and Guardian Angel are all part of Octopus Group, working together to advance our mission.